Pardis Yousefi Talouki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pardis Yousefi Talouki has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hamid Reza Samadikhah
Department of Biology, Islamic Azad University, Central Tehran Branch, Tehran, Iran
1 shared publication Moein Mahmoodi
Department of Biomedical Engineering, Islamic Azad University, Science and Research Branch, Iran
1 shared publication- Moein Mahmoodi
Department of Biomedical Engineering, Islamic Azad University, Science and Research Branch, Iran
1 shared publication Reyhaneh Tamimi
Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
1 shared publication- Reyhaneh Tamimi
Faculty of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
1 shared publication - Reyhaneh Tamimi
Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
1 shared publication
Latest Publications
- 19 February 2026
- Published by Elsevier in Tissue and Cell
- Vol. 101, 103405
Engineering the cartilage niche: Mimicking the microenvironment for functional outcomes
- 19 February 2026
- Published by Elsevier in Tissue and Cell
- Vol. 101, 103405
Engineering the cartilage niche: Mimicking the microenvironment for functional outcomes
- Open Access
- 29 September 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-52
A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering
Articular cartilage’s avascular and aneural nature severely limits its intrinsic regenerative capacity, making injuries and degenerative diseases like osteoarthritis a significant clinical challenge. This review comprehensively examines the paradigm shift towards regenerative medicine strategies, focusing on the integration of the natural polyphenol curcumin into advanced cartilage tissue engineering. While curcumin possesses potent multi-modal therapeutic properties—including anti-inflammatory, antioxidant, anti-catabolic, and chondroprotective effects—its clinical translation is hindered by poor bioavailability and rapid metabolism. We explore innovative biomaterial-based solutions to these limitations, detailing the development of sophisticated DDSs such as nanoparticles, hydrogels (e.g., chitosan, gelatin methacrylate), and synthetic scaffolds (e.g., PCL, PLGA) that enable targeted, sustained release. The review critically analyzes the transition from conventional surgical techniques to emerging therapies like MSC-based treatments, gene therapy, and 3D-bioprinted constructs. Furthermore, we synthesize compelling clinical evidence demonstrating that bioavailable curcumin formulations (e.g., Meriva®, Theracurmin®) significantly improve pain, stiffness, and functional scores in OA and RA patients. By bridging cutting-edge biomaterial science with the ancient therapeutic wisdom of curcumin, this review highlights a promising frontier in restoring joint integrity and offers a critical roadmap for future research in combinatorial regenerative approaches. Graphical abstract
- 29 September 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 16 (1) , 1-52
Open AccessA comprehensive review of curcumin-based scaffolds in cartilage tissue engineering
Articular cartilage’s avascular and aneural nature severely limits its intrinsic regenerative capacity, making injuries and degenerative diseases like osteoarthritis a significant clinical challenge. This review comprehensively examines the paradigm shift towards regenerative medicine strategies, focusing on the integration of the natural polyphenol curcumin into advanced cartilage tissue engineering. While curcumin possesses potent multi-modal therapeutic properties—including anti-inflammatory, antioxidant, anti-catabolic, and chondroprotective effects—its clinical translation is hindered by poor bioavailability and rapid metabolism. We explore innovative biomaterial-based solutions to these limitations, detailing the development of sophisticated DDSs such as nanoparticles, hydrogels (e.g., chitosan, gelatin methacrylate), and synthetic scaffolds (e.g., PCL, PLGA) that enable targeted, sustained release. The review critically analyzes the transition from conventional surgical techniques to emerging therapies like MSC-based treatments, gene therapy, and 3D-bioprinted constructs. Furthermore, we synthesize compelling clinical evidence demonstrating that bioavailable curcumin formulations (e.g., Meriva®, Theracurmin®) significantly improve pain, stiffness, and functional scores in OA and RA patients. By bridging cutting-edge biomaterial science with the ancient therapeutic wisdom of curcumin, this review highlights a promising frontier in restoring joint integrity and offers a critical roadmap for future research in combinatorial regenerative approaches. Graphical abstract
- 21 August 2022
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (17) , 1360-1374
Polyglycerol sebacate (PGS)-based composite and nanocomposites: properties and applications
Nowadays, elastomeric materials with a wide range of properties as a valuable strategy play a wide role in meeting the needs of reconstructive medicine and tissue engineering. In the last two decades, poly glycerol sebacate has shown great potential in the medical industry, especially in the engineering of soft tissues. Although PGS has an elastomeric and biocompatibility nature, it has poor mechanical properties. To overcome this problem, different composites and nanocomposites with hydroxyapatite, carbon nanotubes, graphene, etc. can be used. In this study, we review the properties of PGS-based composite and nanocomposites, as well as their applications in tissue engineering. Graphical Abstract
- 21 August 2022
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 72 (17) , 1360-1374
Polyglycerol sebacate (PGS)-based composite and nanocomposites: properties and applications
Nowadays, elastomeric materials with a wide range of properties as a valuable strategy play a wide role in meeting the needs of reconstructive medicine and tissue engineering. In the last two decades, poly glycerol sebacate has shown great potential in the medical industry, especially in the engineering of soft tissues. Although PGS has an elastomeric and biocompatibility nature, it has poor mechanical properties. To overcome this problem, different composites and nanocomposites with hydroxyapatite, carbon nanotubes, graphene, etc. can be used. In this study, we review the properties of PGS-based composite and nanocomposites, as well as their applications in tissue engineering. Graphical Abstract